好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Characteristics and Outcomes among Acute Ischemic Stroke Patients Arriving to the Hospital Via the "Front Door" vs. Transfer from Another Acute Care Hospital
Cerebrovascular Disease and Interventional Neurology
S49 - (-)
006
Many patients are transferred to academic stroke centers for advanced AIS care, especially after IV tPA, we determined the differences between the two cohorts.
Using our Get with the Guidelines-Stroke registry, we analyzed 1832 consecutively admitted AIS cases (01/09 - 06/12). Univariate and multivariable models explored differences in front door vs. transfer-in patients.
875/1832 (52%) of cases were transfers-in. Compared to front door patients, transfers-in were more likely to be younger (67.2 卤 15.4 vs. 70.8 卤 15.5; p<0.001) have greater median initial NIHSS (7.0 vs. 3.0; p<0.001), more often limb weakness (63% vs. 57%; p=0.02) and aphasia (30% vs. 22%; p<0.001) and receive IV tPA (33% vs. 16%; p<0.001). Despite these differences, in-hospital mortality was similar (13% vs. 11%; p=0.35) between the two groups. Transfer-in patients had a longer hospital length of stay (6.0 卤 6.2 d vs. 4.7 卤 5.2 d; p<0.001) and survivors were more likely to be discharged to inpatient rehabilitation facilities (48% vs. 34%; p<0.001). Independent predictors of in-hospital mortality among all 1832 patients were increasing age [OR 1.03 per yr (95% CI 1.02 - 1.05); p<0.001], history of atrial fibrillation [OR 1.53 (95% CI 1.06 - 2.23); p=0.03], and higher initial NIHSS [1.19/point (95% CI 1.16 - 1.22); p<0.001]. Mode of presentation (front door vs. transfer-in) was not associated with in-hospital mortality.
Transfers of care to our stroke center were common, and these patients were more severely disabled on arrival. Despite this, transfer-in patients had similar in-hospital mortality and increased frequency of discharge to rehabilitation centers. These outcomes support the concept of regionalized stroke care and concentrating sicker patients at more advanced centers.
Authors/Disclosures
Syed T. Ali, MBBS, BSc, MD (Syed T Ali MD PLLC)
PRESENTER 		No disclosure on file
Aneesh B. Singhal, MD, FAAN (Massachusetts General Hospital) An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (好色先生) with Biogen.
Natalia S. Rost, MD, MPH, FAAN, FAHA (Massachusetts General Hospital) Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for 好色先生. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Alasdair Coles, MD, PhD (University of Cambridge) Dr. Coles has nothing to disclose.
Lee H. Schwamm, MD, FAAN (Yale New Haven Health System) Dr. Schwamm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Prime 好色先生. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for lifeimage. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for mediasphere. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving as a Consultant for medscape/WebMD. Dr. Schwamm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Penumbra. Dr. Schwamm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Schwamm has received research support from NINDS. The institution of Dr. Schwamm has received research support from PCORI. Dr. Schwamm has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Schwamm has received publishing royalties from a publication relating to health care. Dr. Schwamm has a non-compensated relationship as a Board of directors with American heart association that is relevant to AAN interests or activities.